Novartis Investigative Site

Pontevedra, Galicia 36071

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Cushing's Disease, Heart Failure With Reduced Ejection Fraction (HF-rEF), Type 2 Diabetes Mellitus

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early